Company Filing History:
Years Active: 2024
Title: Dara Burdette: Innovator in Type I Interferon Production
Introduction
Dara Burdette is a dedicated inventor based in Berkeley, California. He has made significant contributions to the field of immunology through his innovative research and patented inventions.
Latest Patents
Dara Burdette holds a patent for "Cyclic di-nucleotide induction of type I interferon." This invention encompasses methods and compositions designed to enhance the production of type I interferon (IFN) within cells. The patent details methods that involve increasing the levels of a 2′-5′ phosphodiester linkage, specifically utilizing cyclic-di-nucleotides, in a manner sufficient to elevate the production of type I interferon by the cells. The patent also includes compositions and kits capable of practicing the methods outlined.
Career Highlights
Dara Burdette is currently associated with the University of California, where he continues to advance his research in immunology. His innovative work has positioned him as a prominent figure in the field, contributing to the understanding of cellular responses involving interferons.
Collaborations
Throughout his career, Dara has collaborated with notable colleagues, including Russell E. Vance and Ming Chen Hammond. These partnerships have fostered an environment of innovation and discovery, leading to advancements in research and practical applications.
Conclusion
Dara Burdette's contributions to the field of immunology, particularly through his patented methods for inducing type I interferon, reflect his commitment to scientific advancement. His ongoing work at the University of California and collaborations with esteemed colleagues underscore his role as an influential inventor in this crucial area of research.